DrugPatentWatch Database Preview

ASMANEX HFA Drug Profile

  Purchase this report

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Asmanex Hfa patents expire, and when can generic versions of Asmanex Hfa launch?

Asmanex Hfa is a drug marketed by Merck Sharp Dohme and is included in one NDA.

The generic ingredient in ASMANEX HFA is mometasone furoate. There are twenty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.

Summary for ASMANEX HFA

US Patents:	0
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	57
Clinical Trials:	10
Patent Applications:	4,161
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for ASMANEX HFA
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for ASMANEX HFA
DailyMed Link:	ASMANEX HFA at DailyMed

Pharmacology for ASMANEX HFA

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Medical Subject Heading (MeSH) Categories for ASMANEX HFA

Anti-Allergic Agents

Anti-Inflammatory Agents

Dermatologic Agents

US Patents and Regulatory Information for ASMANEX HFA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Merck Sharp Dohme	ASMANEX HFA	mometasone furoate	AEROSOL, METERED;INHALATION	205641-001	Apr 25, 2014		RX	Yes	No
Merck Sharp Dohme	ASMANEX HFA	mometasone furoate	AEROSOL, METERED;INHALATION	205641-002	Apr 25, 2014		RX	Yes	Yes

  Purchase this report

see a sample report or, see our see our flat-rate plans

Expired US Patents for ASMANEX HFA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Merck Sharp Dohme	ASMANEX HFA	mometasone furoate	AEROSOL, METERED;INHALATION	205641-002	Apr 25, 2014
Merck Sharp Dohme	ASMANEX HFA	mometasone furoate	AEROSOL, METERED;INHALATION	205641-001	Apr 25, 2014
Merck Sharp Dohme	ASMANEX HFA	mometasone furoate	AEROSOL, METERED;INHALATION	205641-002	Apr 25, 2014
Merck Sharp Dohme	ASMANEX HFA	mometasone furoate	AEROSOL, METERED;INHALATION	205641-001	Apr 25, 2014
Merck Sharp Dohme	ASMANEX HFA	mometasone furoate	AEROSOL, METERED;INHALATION	205641-002	Apr 25, 2014
Merck Sharp Dohme	ASMANEX HFA	mometasone furoate	AEROSOL, METERED;INHALATION	205641-001	Apr 25, 2014
Merck Sharp Dohme	ASMANEX HFA	mometasone furoate	AEROSOL, METERED;INHALATION	205641-001	Apr 25, 2014

  Purchase this report

see a sample report or, see our see our flat-rate plans